Select the image to view the label in detail.
Selank research profile
What is being studied?
Selank is a seven-residue synthetic analogue formed from the tuftsin sequence extended with Pro-Gly-Pro. It is studied as a regulatory-peptide reference in preclinical transcriptomic systems.
Published mouse, rat and cell-line studies have examined inflammatory and neurotransmission-associated gene panels. Reported changes vary with tissue, time point and experimental context.
Research areas
- Tuftsin-analogue and fragment comparisons
- Cytokine and chemokine gene-expression panels
- GABAergic neurotransmission-associated transcription studies
Selected studies
How to read this research
These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.
Selank research record
Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this 10-vial case.
Molecular identity
Synthetic tuftsin analogue heptapeptide
Sequence / composition
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.